Suggest Avoiding Savaysa for A Fib if CrCl is OVER 95 mL/min
Savaysa (sa-VAYE-sah, edoxaban) will be the fourth new oral anticoagulant...after Pradaxa, Xarelto, and Eliquis.
It's approved for atrial fib and venous thromboembolism (VTE).
But Savaysa has an odd twist when used for A fib. It does NOT work as well as warfarin in patients with NORMAL kidney function.